Trials / Completed
CompletedNCT04603378
A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects Using a Stable Isotope
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Kaleido Biosciences · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This exploratory, randomized, double-blind, placebo-controlled study aims to explore the effect of novel glycans on nitrogen metabolism in the gut in healthy subjects using a stable isotope.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | KB195 | KB195 is a novel glycan |
| OTHER | Polydextrose | Polydextrose is an oligosaccharide |
| OTHER | Pullulan | Pullulan is an oligosaccharide |
| OTHER | Maltodextrin | Maltodextrin is a digestible carbohydrate |
Timeline
- Start date
- 2017-09-18
- Primary completion
- 2017-11-28
- Completion
- 2017-11-28
- First posted
- 2020-10-26
- Last updated
- 2020-10-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04603378. Inclusion in this directory is not an endorsement.